“Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study”, Clinics, vol. 72, no. 6, pp. 378–385, Jun. 2017, doi: 10.6061/clinics/2017(06)08.